Dickinson Andrew D sold GILD
January 31, 2025 · Form 4 insider transaction
Dickinson Andrew D sold 142,180 shares of Gilead Sciences, Inc. at $97.22 per share, a transaction worth $13.82M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
142,180
Price
$97.22
Total value
$13.82M
InsiderDickinson Andrew D
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 31, 2025
Filing dateFebruary 3, 2025
Shares owned after129,873
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.; Sales prices reported for the transactions reported here range from $97.22 to $97.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.